Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

PRE

Prenetics Global Limited

Apr 18 • 04:00PM ET

3.19

Dollar change +0.04
Percentage change 1.27	%

Healthcare • Diagnostics & Research • Hong Kong • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.85	Insider Own	37.19%	Shs Outstand	12.13M	Perf Week	-16.44%
Market Cap	38.69M	Forward P/E	-	EPS next Y	-0.74	Insider Trans	0.00%	Shs Float	7.62M	Perf Month	-30.80%
Income	-64.82M	PEG	-	EPS next Q	-1.02	Inst Own	10.34%	Short Float	0.17%	Perf Quarter	-28.31%
Sales	33.69M	P/S	1.15	EPS this Y	-42.18%	Inst Trans	-15.42%	Short Ratio	0.16	Perf Half Y	-51.89%
Book/sh	18.67	P/B	0.17	EPS next Y	79.39%	ROA	-19.70%	Short Interest	0.01M	Perf Year	-74.03%
Cash/sh	6.00	P/C	0.53	EPS next 5Y	-	ROE	-25.15%	52W Range	3.13 - 15.90	Perf YTD	-46.02%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-31.28%	52W High	-79.94%	Beta	-0.04
Dividend TTM	-	Quick Ratio	2.08	Sales past 5Y	-46.07%	Gross Margin	42.48%	52W Low	1.75%	ATR (14)	0.35
Dividend Ex-Date	Nov 04, 2015	Current Ratio	2.16	EPS Y/Y TTM	87.07%	Oper. Margin	-159.69%	RSI (14)	33.01	Volatility	9.40% 10.06%
Employees	-	Debt/Eq	0.08	Sales Y/Y TTM	-81.66%	Profit Margin	-192.41%	Recom	1.00	Target Price	9.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-15980.81%	Payout	-	Rel Volume	0.89	Prev Close	3.15
Sales Surprise	-27.62%	EPS Surprise	89.34%	Sales Q/Q	-89.62%	Earnings	Apr 01 BMO	Avg Volume	80.91K	Price	3.19
SMA20	-17.92%	SMA50	-29.09%	SMA200	-50.85%	Trades		Volume	71,119	Change	1.27%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-18-23	Initiated	Cantor Fitzgerald	Overweight	$7

Apr-01-24 01:53PM	PRE Stock Earnings: Prenetics Global Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
07:30AM	Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-09-24 09:25AM	Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station (GlobeNewswire)
Nov-20-23 06:00AM	Prenetics Announces Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-01-23 06:00AM	Prenetics Global Limited Announces Reverse Stock Split (GlobeNewswire)
07:10AM	Loading…
Sep-15-23 07:10AM	Prenetics Announces Second Quarter 2023 Financial Results (PR Newswire)
Aug-29-23 12:46AM	A World's First: The Miss Hong Kong Pageant 2023 Unveiled Contestants' CircleDNA Results Live on Television (PR Newswire)
Jun-30-23 08:00AM	Prenetics Global signs "transformational" $200mln deal to create cancer screening JV (News Direct) +5.65%
Jun-26-23 09:30AM	Prenetics Announces $200M JV with Prof. Dennis Lo for Multi-Cancer Early Detection Screening (Exec Edge)
Jun-25-23 08:45PM	Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture Insighta for Breakthrough Multi-Cancer Early Detection Screening (GlobeNewswire)
Jun-05-23 07:20AM	Prenetics Announces First Quarter 2023 Financial Results (PR Newswire) +7.97%
Mar-14-23 08:56AM	Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results (PR Newswire) -6.40%
Mar-02-23 07:00AM	Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology (PR Newswire)
Feb-02-23 04:01PM	Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-19-23 05:00AM	Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA (PR Newswire) -5.52%
10:00AM	Loading…
Jan-17-23 10:00AM	Sidoti's January Micro-Cap Conference (ACCESSWIRE) -13.56%
Jan-10-23 08:05AM	Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors (PR Newswire) +22.04%
Dec-16-22 06:27AM	Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology (GlobeNewswire) +17.10%
Nov-30-22 09:15AM	Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index (PR Newswire)
Nov-10-22 08:00AM	Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance (GlobeNewswire)
Sep-09-22 11:17AM	Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook (PR Newswire) +11.81%
Aug-12-22 09:34AM	The past year for Prenetics Global (NASDAQ:PRE) investors has not been profitable (Simply Wall St.)
Aug-08-22 04:45AM	Prenetics Launches Circle Snapshot, Simple At-home Blood Tests Using the World's First Push-Button and Painless Blood Collection Device (PR Newswire)
Jul-16-22 08:03AM	What Kind Of Investors Own Most Of Prenetics Global Limited (NASDAQ:PRE)? (Simply Wall St.)
Jun-08-22 12:56PM	Prenetics Launches ColoClear, a Non-Invasive Stool DNA Test to Detect Early Signs of Colorectal Cancer in Hong Kong (PR Newswire)
Jun-06-22 09:55AM	Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker "PRE" (PR Newswire)
May-23-22 12:00PM	Video Highlights Covid Testing The English Premier League and Beyond: Join CEOs of Prenetics, Artisan in Fireside Chat (IPO-Edge.com)
08:46AM	New Horizon Health Partners with Prenetics in Hong Kong to Launch ColoClear, a Non-Invasive Stool DNA Test to Detect Colon Cancer (PR Newswire)
May-19-22 12:15PM	Replay Covid Testing The English Premier League and Beyond: Join CEOs of Prenetics, Artisan in Fireside Chat (IPO-Edge.com) -26.41%
May-18-22 06:30PM	Prenetics Rings the Opening Bell and Debuts on Nasdaq (GlobeNewswire)
11:00AM	Loading…
May-17-22 11:00AM	Covid Testing The English Premier League and Beyond : Join CEOs of Prenetics, Artisan in Fireside 10AM ET Thurs (IPO-Edge.com)

Prenetics Global Ltd. is a genomics-driven health sciences company, which engages in the prevention, early detection, and treatment of diseases. It operates through the Prevention and Diagnostic segments. The Prevention segment is involved in the design and sale of genetics testing and stool-based DNA tests for early colorectal cancer screening. The Diagnostic segment consists of COVID-19 testing services and products, and precision oncology services. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRE

Prenetics Global Limited

Upgrade your FINVIZ experience